Literature DB >> 25940951

Schistosoma mansoni and HIV acquisition in fishing communities of Lake Victoria, Uganda: a nested case-control study.

Ali Ssetaala1, Jessica Nakiyingi-Miiro2,3, Gershim Asiki2, Nassim Kyakuwa2, Juliet Mpendo1, Govert J Van Dam4, Paul L Corstjens4, Pietro Pala2, Leslie Nielsen5, Jan De Bont5, Giuseppe Pantaleo6, Noah Kiwanuka1,7, Pontiano Kaleebu2,3,8, Anatoli Kamali2,8, Alison M Elliott2,3.   

Abstract

OBJECTIVE: It has been suggested that Schistosoma mansoni, which is endemic in African fishing communities, might increase susceptibility to human immunodeficiency virus (HIV) acquisition. If confirmed, this would be of great public health importance in these high HIV-risk communities. This study was undertaken to determine whether S. mansoni infection is a risk factor for HIV infection among the fishing communities of Lake Victoria, Uganda. We conducted a matched case-control study, nested within a prospective HIV incidence cohort, including 50 HIV seroconverters (cases) and 150 controls during 2009-2011.
METHODS: S. mansoni infection prior to HIV seroconversion was determined by measuring serum circulating anodic antigen (CAA) in stored serum. HIV testing was carried out using the Determine rapid test and infection confirmed by enzyme-linked immunosorbent assays.
RESULTS: About 49% of cases and 52% of controls had S. mansoni infection prior to HIV seroconversion (or at the time of a similar study visit, for controls): odds ratio, adjusting for ethnicity, religion, marital status, education, occupation, frequency of alcohol consumption in previous 3 months, number of sexual partners while drunk, duration of stay in the community, and history of schistosomiasis treatment in the past 2 years was 1.23 (95% CI 0.3-5.7) P = 0.79. S. mansoni infections were chronic (with little change in status between enrolment and HIV seroconversion), and there was no difference in median CAA concentration between cases and controls.
CONCLUSIONS: These results do not support the hypothesis that S. mansoni infection promotes HIV acquisition.
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Schistosoma mansonizzm321990; zzm321990VIHzzm321990; HIV; Ouganda; Schistosoma mansoni; Uganda; antigène anodique circulant; antígeno anódico circulante; circulating anodic antigen; communautés de pêcheurs; comunidades de pescadores; fishing communities; sensibilité; susceptibilidad; susceptibility

Year:  2015        PMID: 25940951      PMCID: PMC4529482          DOI: 10.1111/tmi.12531

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


Introduction

Fishing communities in Uganda are disproportionately affected by HIV infection with incidence and prevalence four times the national average, or more 1, 2. These figures are attributed to high‐risk sexual behaviour and limited access to health services 1, 2. Schistosoma mansoni, a chronic, immunomodulating helminth infection, highly prevalent in fishing communities, may be an additional risk factor in these communities 3. It is estimated that over 16 million Ugandans are at risk of schistosomiasis and more than 4 million infected 4. S. haematobium is a potential risk factor for HIV acquisition, because it directly affects the genital mucosa 5. S. mansoni infection has also been linked to increased risk of acquiring simian–human immunodeficiency virus (SHIV) and HIV in primate and human studies, respectively 3, 6, 7. Proposed systemic immunological mechanisms for this include up‐regulation of HIV co‐receptors and of Th2 T cells in which HIV may replicate more efficiently 3, 8. If confirmed, this would imply that control of S. mansoni, as well as of S. haematobium, could contribute to reducing the HIV reservoir among fishing communities and hence spread to the general population. We conducted a matched case–control study, nested within a prospective HIV incidence study, to determine whether S. mansoni infection promotes HIV acquisition in Ugandan fishing communities.

Methods

The study was conducted among five fishing communities on Lake Victoria, Uganda. This was a matched case–control study nested within a prospective HIV incidence cohort of 1000 individuals (males and females, aged 13–49 years) recruited in 2009, and followed for 18 months 2. Within the prospective cohort, data on risk factors for HIV acquisition, and serum samples for HIV testing and storage, were obtained at enrolment and at six‐monthly follow‐up intervals. HIV testing was carried out using Determine rapid tests (Abbott Laboratories, Chicago, IL, USA), confirmed by enzyme‐linked immunosorbent assays (ELISA; Vironostika HIV Uni‐Form II plus 0 microelisa system, Biomerieux, Boxtel, Netherlands and Murex HIV‐1.2.0, Murex, Biotech Limited, Dartford, UK), with Western blot (Calypte Biomedical Corporation, Rockville, Maryland, USA) if ELISA results were indeterminate. During follow‐up, 59 individuals became HIV‐1 positive 2. All cases available and willing to participate were selected. Fifty HIV seroconverters were included as cases, with 150 controls selected from those who remained HIV negative. For every case, three controls matched on age, sex and community of residence were randomly selected by computer using StataSE12 (1985–2011 StataCorp, College Station, TX, USA). Controls that were not willing to participate or could not be traced after more than three attempts were replaced. At the case–control study visit, participants were interviewed regarding schistosomiasis risk factors. Stored serum was tested for Schistosoma circulating anodic antigen (CAA) at cohort enrolment, 6, 12 and 18 months using CAA‐specific up‐converting phosphor technology‐based lateral flow assay strips (UPT‐LF) 9, 10, and a CAA value ≥ 32 pg/ml was considered positive. Although CAA cannot distinguish S. mansoni from S. haematobium, the latter has not been found on the Ugandan shores of Lake Victoria 11, so a positive result was taken as indicative of S. mansoni infection. For cases, CAA serostatus was taken as the result for the last sample before HIV seroconversion. For controls, CAA serostatus was taken as the result for the sample corresponding to the last visit before HIV seroconversion for the matched case. Stool samples were also collected during the case–control study visit (after the end of cohort follow‐up), for three consecutive days, to test for S. mansoni infection. Two laboratories participated. Microscopy was performed using the Kato–Katz method in one location, formol–ether concentration in the other location. Intensity of infection was defined based on WHO criteria as light (<100 eggs per gram (epg), moderate (100–399 epg) and heavy (≥400 epg). Participants diagnosed with HIV infection (during follow‐up) were referred to The AIDS Support Organization (TASO) and Entebbe Hospital for care and treatment according to the Uganda Ministry of Health guidelines. Those diagnosed with S. mansoni infection (after the end of follow‐up) were treated with single‐dose praziquantel, 40 mg/kg. Participants diagnosed with other helminth infections were treated with a single dose of albendazole 400 mg. Data were double‐entered using MS Access 2003 (1992–2003 Microsoft Corporation, Redmond, Washington, USA) and analysed using StataSE12. The outcome was HIV seroconversion during follow‐up. The aim was to determine whether S. mansoni infection (assessed by serum CAA) was associated with the outcome (HIV seroconversion during follow‐up). Associations between stool microscopy results and serum CAA were also investigated. Baseline age, sex and community of residence were matching factors. Matched conditional logistic regression was used to investigate univariable associations between HIV seroconversion and other demographic factors (marital status, education status, occupation, religion and behavioural risk factors; being away from home for at least two nights in the previous month; frequency of alcohol use; and number of sexual partners while under the influence of alcohol or drugs during the previous 3 months) and to investigate risk factors for S. mansoni infection (duration of stay in fishing community and history of treatment for schistosomiasis in the preceding 2 years). Covariates considered a priori to be potential confounders (marital status, religion and ethnicity) and those associated with S. mansoni at P ≤ 0.1 were assessed for confounding by adding them individually to the multivariable model and tested for goodness of fit using log likelihood ratio test. If the S. mansoni–HIV effect measure changed by 10% or more, the covariate was retained in the final model. The study was approved by Uganda Virus Research Institute Science and Ethics Committee (FWA number 00001354) and the Uganda National Council of Science and Technology (FWA number 00001293). Participants aged 18 years and above were enrolled after giving written informed consent. Those aged 13–17 years were enrolled after written assent, with consent from their parents or guardians.

Results

Socio‐demographic characteristics

Characteristics of the cohort have been described 2. Among the 200 participants enrolled into this nested study, median age was 25 years (IQR 22–30 years). The highest proportion was males (56%), Roman Catholics (41%), married (63%), with incomplete primary‐level education (41%) and worked in fishing‐related jobs (66%).

Schistosomiasis

The majority of participants (76%) had not received S. mansoni (praziquantel) treatment in the previous 2 years. Determination of S. mansoni infection status was based on serum CAA. Half (51%) had S. mansoni infection at cohort enrolment, 48%, 52% and 52% at 6, 12 and 18 months, respectively. There was 96% agreement between the CAA status at enrolment and CAA status at the pre‐seroconversion (or equivalent control) time point (κ=0.91, P < 0.001). Compared to the stool results, serum CAA had a sensitivity of 84%, specificity 92% and a positive predictive value of 94%. Intensity of S. mansoni infection was assessed in 79 samples examined by the Kato–Katz method. Of those infected, 61% had light, 29% moderate and 10% heavy infections. S. mansoni prevalence was highest in the 25–29 years age group, [66%, P < 0.001], higher among males than females [75% vs. 21%, P < 0.001] and increased with declining education level [P = 0.035]. Almost all participants who were engaged in fishing had S. mansoni infection [54/58, 93%; P < 0.001 compared to other occupational groups]. Being away from home frequently [P = 0.009] and long‐term residence in the fishing community [P = 0.012] were associated with S. mansoni infection.

Association between S. mansoni infection and HIV acquisition

There was no difference between cases who acquired HIV infection, and controls who had not, in S. mansoni infection status based on CAA results at the preceding visit: 49% of cases and 52% of controls had S. mansoni infection [OR 0.83 (95% CI 0.39–1.77) P = 0.63]. The result was similar after adjusting for ethnicity, religion, marital status, education, occupation, frequency of alcohol consumption in previous 3 months, number of sexual partners while drunk, duration of stay in the community and history of schistosomiasis treatment (praziquantel) in the past 2 years [aOR 1.23 (95% CI 0.3–5.7) P = 0.79]. There was also no difference in median CAA concentration between cases and controls: 2906 and 6530 pg/ml, respectively (P = 0.16). Factors associated with HIV acquisition in the case–control study were similar to those previously reported for the whole cohort: occupation, religion, frequency of alcohol consumption (2); Table 1. In addition, not having taken praziquantel treatment for Schistosomiasis in the last 2 years was associated with HIV acquisition [OR 8.25 (95% CI 1.3–51.1) P = 0.03].
Table 1

Multivariable conditional regression analysis of factors associated with HIV infection

VariableUnadjustedAdjusted
OR95% CIOR95% CI P‐value
Serum CAA0.80.4–1.81.230.3–5.70.79
Marital status
Premarital1 Ref1 Ref0.5
Married Monogamous1.000.4–2.61.140.19–6.76
Married Polygamous0.550.2–2.00.360.33–4.02
Divorced/Widowed1.360.4–4.40.520.55‐4.86
Education Status
Post‐primary1 Ref1 Ref0.94
Completed Primary1.420.6–3.60.640.1–3.9
Incomplete Primary1.200.5–2.80.940.2–5.2
None1.610.5–5.31.000.1–8.5
Occupation
Fishing1 Ref1 Ref<0.005
Fishing related1.130.4–3.113.541.8–101.3
Bar/Hotel/restaurant2.920.6–15.141.531.6–1071.3
Business/trade0.490.1–2.60.320.0–6.3
Farming1.570.4–6.08.840.7–110.6
Other jobs2.220.5–10.54.000.3–52.5
Not earning1.854.78
Religion
Catholic1 Ref1 Ref0.018
Anglican5.562.3–13.57.981.8–35.4
Muslim1.650.7–3.92.730.7–10.9
Other1.700.4–7.29.060.7–112.3
Ethnicity
Non‐Muganda1 Ref1 Ref0.32
Muganda0.80.4–1.60.500.1–2.0
Alcohol use
Never1 Ref1 Ref0.013
Rarely1.920.8–4.89.211.4–61.8
Regularly3.491.6–7.86.851.3–37.4
Duration of stay
5–45 years1 Ref1 Ref<0.005
<5 years3.771.6–8.67.561.5–37.6
Bilharzia treatment in last 2 years
Yes1 Ref1 Ref0.034
No2.491.0–6.38.251.3–51.1
Sexual partners while drunk(pre‐infection)
01 Ref1 Ref0.98
11.960.8–4.70.670.1–3.2
≥ 21.580.4–6.00.480.0–7.0
Multivariable conditional regression analysis of factors associated with HIV infection

Discussion and conclusion

We found that S. mansoni infection was not associated with HIV acquisition among adults in Lake Victoria fishing villages. As opposed to S. haematobium, S. mansoni is unlikely to cause genital lesions. This result therefore suggests that systemic immune modulation by S. mansoni does not significantly increase susceptibility to HIV acquisition. By contrast, an experiment in macaques showed increased susceptibility to a simian–human immunodeficiency virus (SHIV) infection in S. mansoni‐infected animals 6. However, the macaque schistosome infections were recent at the time of SHIV exposure (7 weeks), egg counts were equivalent to moderate to heavy human infections, and the virus was administered rectally, encountering tissues directly affected by S. mansoni egg‐induced lesions. By contrast, our human participants had chronic S. mansoni infections (few had recently been treated, and status had not changed between enrolment and the pre‐seroconversion visit), many had light infections, and HIV infection would usually have occurred via the genital mucosa. Indeed, in a second macaque study, S. mansoni infection did not increase susceptibility when SHIV was administered intravenously, implying that route of infection was critical 7. Cross‐sectional studies have provided conflicting evidence regarding HIV–S. mansoni associations. A survey focussing on women on the Tanzanian shores of Lake Victoria using serum CAA to determine Schistosoma infection found a positive association with HIV infection, and higher CAA levels among HIV‐positive women 12. However, the number of HIV‐infected women was small (21 of 345) so confidence intervals were wide, the prevalence of HIV infection was approximately 4.5 times lower than in the Ugandan fishing villages, and the catchment area extended to 25 km from the lake, so that a wide array of potential confounding factors in terms of environment and lifestyle may have come into play. A low prevalence of S. haematobium (3%) might also have contributed. The cross‐sectional design of the Tanzanian study means that the sequence in which the infections occurred is unknown. An earlier study showed no positive association between S. mansoni and HIV infection and highlighted differences in occupation and origin of members of the population affected by the two infections 13. Given the lack of association we observed between S. mansoni infection and HIV acquisition, we were surprised to observe a strong association between HIV infection and lack of praziquantel treatment in the last 2 years. It is difficult to draw robust conclusions from self‐reported behaviour. We presume this may be a marker for poor health‐seeking behaviour, rather than for a biological process. Participants were not examined or treated for S. mansoni by the research team during the cohort study. Strengths of our study were prospective sample collection, recruitment restricted to a relatively uniform (fishing village) community, and matching and adjustment for potential confounders. The CAA assay allowed assessment of S. mansoni infection status at enrolment and immediately prior to HIV seroconversion, demonstrating chronicity of infection, and avoided potential concerns about differential egg excretion among HIV‐positive and HIV‐negative people 14. Although it can be difficult to assess causality in case–control studies, the prospective design of our cohort did allow us to assess Schistosomiasis status prior to HIV acquisition – an important improvement over studies with a cross‐sectional design. While there are many potential benefits of S. mansoni control in heavily infected communities, our results suggest that an impact on HIV transmission is not one of them.
  14 in total

1.  Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia.

Authors:  A L Fontanet; T Woldemichael; T Sahlu; G J van Dam; T Messele; T Rinke de Wit; W Masho; H Yeneneh; R A Coutinho; L van Lieshout
Journal:  Ann Trop Med Parasitol       Date:  2000-03

2.  Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections.

Authors:  D M Karanja; D G Colley; B L Nahlen; J H Ouma; W E Secor
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

Review 3.  Interactions between schistosomiasis and infection with HIV-1.

Authors:  W E Secor
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

Review 4.  Epidemiology, of bilharzias (schistosomiasis) in Uganda from 1902 until 2005.

Authors:  I Odongo Aginya Emmanuel; Doehring Ekkehard
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

Review 5.  Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies.

Authors:  Eyrun F Kjetland; Ingrid Ea Hegertun; Marc Fd Baay; Mathias Onsrud; Patricia D Ndhlovu; Myra Taylor
Journal:  Int J STD AIDS       Date:  2014-03-12       Impact factor: 1.359

6.  High HIV incidence and socio-behavioral risk patterns in fishing communities on the shores of Lake Victoria, Uganda.

Authors:  Janet Seeley; Jessica Nakiyingi-Miiro; Anatoli Kamali; Juliet Mpendo; Gershim Asiki; Andrew Abaasa; Jan De Bont; Leslie Nielsen; Pontiano Kaleebu
Journal:  Sex Transm Dis       Date:  2012-06       Impact factor: 2.830

7.  Schistosoma mansoni enhances host susceptibility to mucosal but not intravenous challenge by R5 Clade C SHIV.

Authors:  Nagadenahalli B Siddappa; Girish Hemashettar; Vivekanandan Shanmuganathan; Amma A Semenya; Elizabeth D Sweeney; Katherine S Paul; Sandra J Lee; W Evan Secor; Ruth M Ruprecht
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

8.  Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda.

Authors:  Narcis B Kabatereine; Claire J Standley; Jose C Sousa-Figueiredo; Fiona M Fleming; J Russell Stothard; Ambrose Talisuna; Alan Fenwick
Journal:  Parasit Vectors       Date:  2011-12-13       Impact factor: 3.876

9.  High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.

Authors:  Noah Kiwanuka; Ali Ssetaala; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Annet Nalutaaya; Paul Kato; Leslie Nielsen; Pontiano Kaleebu; Josephine Nalusiba; Nelson K Sewankambo
Journal:  J Int AIDS Soc       Date:  2013-07-22       Impact factor: 5.396

10.  Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.

Authors:  Agnès-Laurence Chenine; Ela Shai-Kobiler; Lisa N Steele; Helena Ong; Peter Augostini; Ruijiang Song; Sandra J Lee; Patrick Autissier; Ruth M Ruprecht; W Evan Secor
Journal:  PLoS Negl Trop Dis       Date:  2008-07-23
View more
  20 in total

1.  Decreased Sensitivity of Schistosoma sp. Egg Microscopy in Women and HIV-Infected Individuals.

Authors:  Soledad Colombe; Myung Hee Lee; Peter J Masikini; Lisette van Lieshout; Claudia J de Dood; Pytsje T Hoekstra; Paul L A M Corstjens; Julius Mngara; Govert J van Dam; Jennifer A Downs
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

2.  Schistosomiasis and Human Immunodeficiency Virus in Men in Tanzania.

Authors:  Jennifer A Downs; Claudia J de Dood; Hannah E Dee; Megan McGeehan; Hijab Khan; Abena Marenga; Patrick E Adel; Edward Faustine; Benson Issarow; Emmanuel F Kisanga; Godfrey Alfred Kisigo; Salvius Ngahyolerwa; Frank Zahoro; Donald Miyaye; Ruth Gideon Magawa; Julius Mngara; Myung Hee Lee; Paul L A M Corstjens; Govert J van Dam; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

3.  Interactions of Schistosoma and HIV in Sub-Saharan Africa: A Systematic Review.

Authors:  Briana D Furch; John R Koethe; Violet Kayamba; Douglas C Heimburger; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

4.  Cervicovaginal bacterial communities in reproductive-aged Tanzanian women with Schistosoma mansoni, Schistosoma haematobium, or without schistosome infection.

Authors:  Brooke W Bullington; Myung Hee Lee; Jane Mlingi; Ndalloh Paul; Christine Aristide; Emily Fontana; Eric R Littmann; Crispin Mukerebe; Peter Shigella; Philibert Kashangaki; Samuel E Kalluvya; Claudia J de Dood; Govert J van Dam; Paul L A M Corstjens; Daniel W Fitzgerald; Eric G Pamer; Jennifer A Downs
Journal:  ISME J       Date:  2021-01-06       Impact factor: 10.302

5.  Schistosoma mansoni and HIV infection in a Ugandan population with high HIV and helminth prevalence.

Authors:  Richard E Sanya; Lawrence Muhangi; Margaret Nampijja; Victoria Nannozi; Prossy Kabuubi Nakawungu; Elson Abayo; Emily L Webb; Alison M Elliott
Journal:  Trop Med Int Health       Date:  2015-06-01       Impact factor: 2.622

6.  Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher Folk.

Authors:  Andrew Ekii Obuku; Gershim Asiki; Andrew Abaasa; Isaac Ssonko; Alexandre Harari; Govert J van Dam; Paul L Corstjens; Moses Joloba; Song Ding; Juliet Mpendo; Leslie Nielsen; Anatoli Kamali; Alison M Elliott; Giuseppe Pantaleo; Pontiano Kaleebu; Pietro Pala
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

7.  The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.

Authors:  Anne Wajja; Dennison Kizito; Beatrice Nassanga; Angela Nalwoga; Joyce Kabagenyi; Simon Kimuda; Ronald Galiwango; Gertrude Mutonyi; Samantha Vermaak; Iman Satti; Jaco Verweij; Edridah Tukahebwa; Stephen Cose; Jonathan Levin; Pontiano Kaleebu; Alison M Elliott; Helen McShane
Journal:  PLoS Negl Trop Dis       Date:  2017-05-04

8.  Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study.

Authors:  Jennifer A Downs; Kathryn M Dupnik; Govert J van Dam; Mark Urassa; Peter Lutonja; Dieuwke Kornelis; Claudia J de Dood; Pytsje Hoekstra; Chifundo Kanjala; Raphael Isingo; Robert N Peck; Myung Hee Lee; Paul L A M Corstjens; Jim Todd; John M Changalucha; Warren D Johnson; Daniel W Fitzgerald
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

9.  Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis.

Authors:  Aaron F Bochner; Jared M Baeten; W Evan Secor; Govert J van Dam; Adam A Szpiro; Sammy M Njenga; Paul L A M Corstjens; Austin Newsam; Nelly R Mugo; Connie Celum; Andrew Mujugira; R Scott McClelland; Ruanne V Barnabas
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

10.  Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study.

Authors:  Jessica L Prodger; Aloysious Ssemaganda; Ali Ssetaala; Paul K Kitandwe; Enoch Muyanja; Juliet Mpendo; Annet Nanvubya; Mathias Wambuzi; Leslie Nielsen; Noah Kiwanuka; Rupert Kaul
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.